RJF logo

Laboratorio Reig Jofre, S.A. Stock Price

BME:RJF Community·€201.9m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 10 Fair Values set on narratives written by author

RJF Share Price Performance

€2.48
-0.17 (-6.42%)
€2.48
-0.17 (-6.42%)
Price €2.48

RJF Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Reasonable growth potential with adequate balance sheet.

3 Risks
1 Reward

Laboratorio Reig Jofre, S.A. Key Details

€336.7m

Revenue

€143.5m

Cost of Revenue

€193.2m

Gross Profit

€188.2m

Other Expenses

€5.0m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
May 07, 2026
0.062
57.39%
1.49%
32.0%
View Full Analysis

About RJF

Founded
1929
Employees
1512
CEO
Ignasi Reig
WebsiteView website
reigjofre.com/en

Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmaceuticals, food, and other products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; and food supplements under the Forté Pharma brand. In addition, the company provides CDMO and CMO services; and management and administration services. It sells its products through business partners. The company was founded in 1929 and is headquartered in Barcelona, Spain. Laboratorio Reig Jofre, S.A. operates as a subsidiary of Reig Jofre Investments SL.

Recent RJF News & Updates

Recent updates

No updates